Cargando…
P594: THE CXCR4-LOW/CD5-HIGH PROLIFERATIVE FRACTION IS ENRICHED IN BTK MUTATIONS AND ANTICIPATES RELAPSE IN IBRUTINIB-TREATED CLL
Autores principales: | Pozzo, Federico, Forestieri, Gabriela, Ianna, Giulia, Vit, Filippo, Tissino, Erika, Bittolo, Tamara, Papotti, Robel, Terzi DI Bergamo, Lodovico, Steffan, Agostino, Laureana, Roberta, Tafuri, Agostino, Chiarenza, Annalisa, DI Raimondo, Francesco, Olivieri, Jacopo, Zaja, Francesco, Laurenti, Luca, Ilaria DEL Principe, Maria, Bomben, Riccardo, Zucchetto, Antonella, Rossi, Davide, Gattei, Valter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429438/ http://dx.doi.org/10.1097/01.HS9.0000969280.78541.51 |
Ejemplares similares
-
S143: NATURAL CLONAL EVOLUTION OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH BIMODAL CD49D EXPRESSION REVEALS CD49D PLASTICITY
por: Tissino, Erika, et al.
Publicado: (2023) -
Clinical impact of TP53 disruption in chronic lymphocytic leukemia patients treated with ibrutinib: a campus CLL study
por: Bomben, Riccardo, et al.
Publicado: (2023) -
P606: MEASUREMENT OF INTRACLONAL DIVERSIFICATION REFINES THE PROGNOSTIC IMPACT OF IGHV MUTATIONS IN CLL
por: Vit, Filippo, et al.
Publicado: (2023) -
TP53 Mutations and Clinical Outcome in Chronic Lymphocytic Leukemia: Is a Threshold Still Needed?
por: Bomben, Riccardo, et al.
Publicado: (2023) -
SF3B1-mutated chronic lymphocytic leukemia shows evidence of NOTCH1 pathway activation including CD20 downregulation
por: Pozzo, Federico, et al.
Publicado: (2020)